NCT04477369View on ClinicalTrials.gov

Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

August 31, 2020

Study Completion Date

September 30, 2020

Conditions
Healthy
Interventions
DRUG

DWJ1439

300mg single dose

DRUG

DWJ1464

300mg single dose

DRUG

DWC202003

300mg single dose

DRUG

DWC202004

300mg single dose

Trial Locations (1)

Unknown

RECRUITING

Kyung Hee University Medical Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY